Is It Beneficial To Take Pharma Franchise In The Current Situation?

1. Is It Beneficial To Take Pharma Franchise In The Current Situation? The outbreak of the COVID-19 pandemic has created severe effects on the economy as well as operations in the world. Numerous deaths have been taken place, with many people infected. Almost all Industries have been greatly affected and losses persist to proceed by the day, so the PCD franchise in India is no exception. Having focused on the worldwide trade in pharma products, the current lockdown has caused the trade to go slow and puffed up credit. Therefore, with these unfavorable situations, a second thought has to be given for taking pharma franchise in the country. Four Important Unfavorable Factors for Taking the Pharma Franchise 1. The Export Of Drugs Has Been Restricted India has the credit of meeting the maximum demand for medical drugs of the world. Most of the production of medicines and drugs of the country has been exported to many global countries. It supplies more than 50 percent of the world's total drugs. After the outbreak of COVID-19 In March, the government of India imposed a ban on the exportation of medicines, particularly, antibiotics, paracetamols, and 13 APIs or Active Pharmaceutical Ingredients, fearing that their local supply would be exhausted. 2. Travel Ban Between Indian States Except for China, local towns, like Baddi, Goa, and Sikkim produce finished drugs that contribute to the bulk of national medicines set to be exported. However, because of the lockdown in most towns and the 14-hour curfew rule, transportation between these towns, to the crucial ports for distribution

2. has been severely limited. Currently, the travel between districts has been constrained thus impeding the supply of these medicines. Additionally, the local supply of medicinal products has also been hampered because there is no free movement of basic required medicines throughout the country. 3. Drop In The Manufacture And Rise In Unemployment. There are huge doubts on the production of the pharma industry if the pandemic persists to exist. A sharp decline in the manufacture of medical drugs in India will be a clear-cut outcome if the condition does not stabilize soon. Earlier, PCD pharma companies in Panchkula and other parts of the country stocked up their supply of Active Pharmaceutical Ingredients from China that would be enough for their robust medicine manufacture for the next three months. However, while time continues to pass and no refills are made, the stock of these companies will soon be exhausted, showing the way to an eventual non-manufacture condition. 4. The Decrease In The Revenue For The PCD Franchise The drop in the manufacture of PCD products and limitations on their exportation has led to additional complications. The owners of PCD Franchise businesses are incurring heavy losses because their PCD products sit in numerous warehouses, without the expectation of exportation. To conclude, COVID-19 has had numerous effects on the Indian PCD Franchise Industry. There is a huge possibility for things to get worse if the pandemic continues its disastrous streak. However, recent forecasts have mentioned that the common effects on the pharma business as moderate in view of the likely benefits as well as opportunities presented to India during this difficult time. Thus, with the above-mentioned problems, it is not shrewd and lucrative to take the PCD franchise during this current COVID-19 pandemic. Source Link : https://sites.google.com/view/medbeathealthcare/blog/is-it-beneficial -to-take-pharma-franchise-in-the-current-situation CONTACT DETAILS Medbeat Health Care Plot no.295, Basement, Industrial Area, Phase 2, Panchkula, Haryana-134113 +91 9780230498 medbeathc@gmail.com

3. http://medbeathealthcare.com/